Tempo Launches New Products to Enhance Service and Performance
Tempo, a leader in productivity-enhancing project management solutions, announces four new offerings to our customers.
Premium Success Program
Our Premium Success Program is a new extended service offering, which expands our basic service experience with multiple benefits for enterprise customers, and customers who need mission-critical support.
Customers taking advantage of the Premium Success Program can expect faster responses and 24/7 support. Additionally, customers will have access to a designated customer success resource, development support, annual system health checks, priority access to webinars and onboarding support.
“We understand the importance of a superlative customer experience. Tempo’s Premium Success Program is designed to offer our most demanding customers enhanced support and more options to solve their unique challenges faster,” said Petur Agustsson, CCO of Tempo.
Tempo for Jira Data Center
Tempo is a launch partner in the Atlassian Data Center Apps program, with Tempo for Jira apps officially supporting Jira Data Center deployments.
In this new program, Tempo apps will be verified to support the Data Center deployment option for Jira and validated as providing the best possible user experience and support. Tempo’s state-of-the-art technology provides optimal performance for even the most demanding set-up or environment. By making the apps available to run in a clustered, multi-node environment, Tempo helps to ensure the continuous availability and resilience of business operations. Clustering of servers minimizes downtime and single points of failure, and allows enterprise users to scale without compromising on performance. The enhanced scalability of Tempo for Jira Data Center allows systems to grow with the company in an agile manner, both in terms of licensing and technical set-up.
“Many of our largest customers have already migrated to Jira Data Center,” commented Vidar Svansson, CPO of Tempo, “Launching Tempo for Data Center underscores our commitment to support Tempo at scale.”
Tempo Connect is a new product that connects our cloud products to other business tools.
Tempo is currently the #1 top selling app for Atlassian’s Jira and supports integration with Slack and Chrome. Tempo’s latest integration with QuickBooks allows companies to run payroll and billable hours with secure data from Tempo. Built-in approval functionality enables Tempo to provide better data accuracy as errors are minimized when work is tracked in one place This saves time and effort in tracking and reviewing work logs.
With Tempo Connect, customers with limited resources can focus their time on more meaningful activities than maintaining integrations and duplicating time entries. Customers can get started easily and synchronize their data immediately from Tempo.
“Our customers rely on Tempo data to operate their business. Tempo Connect makes it easier than ever to synchronize Tempo data with other business tools to increase accuracy and minimize duplication of time entries.” commented Vidar Svansson, CPO of Tempo.
Tempo Cloud lift its limit to 5.000 users
“Atlassian Jira Cloud, as well as Tempo Cloud, previously supported deployments of only up to 2,000 users. This limitation has now been increased to 5,000 users, enabling more enterprise customers to choose the cloud hosting option. We are very excited about this change. It strengthens our cloud-first focus and helps us better meet the needs of our enterprise customers,” said Sigurdur Thorarinsson, CTO of Tempo, “Our vision is ultimately to enable our users to work across the entire suite of their chosen tools, with a uniform experience for capturing and managing their productivity.”
Tempo’s core products are Tempo Timesheets for time tracking, reporting and budgeting, Tempo Planner for resource management and project planning, and Tempo Budgets for schedule and cost management across projects and portfolios.
With headquarters in Reykjavik, Iceland and a North American presence in Montreal, Canada, Tempo develops sophisticated software solutions that help make work easier and more efficient for software, IT services and core business teams. Tempo has over 11,000 customers worldwide, ranging from small startups to the largest global enterprises including Amazon, BMW, Pfizer, HomeAway, PayPal, Hulu, Dell, and Disney.
To learn more about Tempo, visit www.tempo.io.
Follow the Tempo blog: http://blog.tempo.io
Follow us on Twitter: http://twitter.com/tempohq
Become a fan on Facebook: http://facebook.com/tempohq
Follow us on LinkedIn: https://www.linkedin.com/company/TempoHQ
+354 532 2000
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
PTC Adds Artificial Intelligence and Generative Design Capabilities to Enhance and Expand its CAD Portfolio with Acquisition of Frustum20.11.2018 15:12 | Tiedote
PTC (NASDAQ: PTC) today announced that it has acquired Frustum Inc., an advanced generative design software company, for approximately $70 million. Frustum’s technology for generative design—an approach that leverages artificial intelligence (AI) to generate design options—is a transformative addition to the PTC Creo portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181120005326/en/ PTC Adds Artificial Intelligence and Generative Design Capabilities to Enhance and Expand its CAD Portfolio with Acquisition of Frustum (Graphic: Business Wire) Based in Boulder, Colorado, Frustum offers patented desktop and cloud-based engineering software that enables designers and engineers to go beyond the limits of their personal experience by leveraging powerful AI capabilities that guide the discovery of high-performance, next-generation product designs. “PTC is pushing the boundaries of innovation with this acquisition,” said Jim
United First Partners Launches UFP Fintech20.11.2018 15:00 | Tiedote
United First Partners (“UFP”), a leading independent Research, Brokerage, Advisory & Investment group is pleased to announce the launch of its latest venture: UFP Fintech. UFP Fintech invests in early stage Fintech, Proptech and Legaltech startups. Under the leadership of the entity’s CIO Christophe Petetin, a veteran investor in the Fintech space with an unparalleled investment track record in Fintech start-ups, UFP Fintech aims to become a global leader in Early Stage Fintech Investments. In recent years, Christophe and the UFP Fintech team have seeded a major unicorn and several other market leading entities. Christophe is a premier Fintech thought leader, who also acts in an advisory capacity to governmental and regulatory bodies, such as the FCA and ISO 20022 to create the next generation of standards for Fintech, payments, data, securities & digital currencies. Christophe commented “The financial industry is getting rebuilt from the ground up creating unprecedented opportunities.
LEO Pharma and PellePharm Announce $760 Million Collaboration to Advance Innovative Therapies for Rare Skin Diseases20.11.2018 14:00 | Tiedote
Danish dermatology specialists LEO Pharma and California rare disease pioneers PellePharm today announced a strategic development and commercialization collaboration to address unmet medical needs across various skin diseases with no approved treatments, advancing innovation and access to potential therapies for patients with life-altering conditions, such as Gorlin Syndrome and High Frequency Basal Cell Carcinoma (BCC), two distinct and rare forms of skin cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181120005227/en/ “We are very excited about the partnership with PellePharm, who are pioneers in Gorlin Syndrome and experts in rare skin diseases. Supporting our ambitious 2025 strategy, it marks LEO Pharma’s entrance in rare skin diseases and it offers a unique opportunity to bring the first treatment forward to people suffering from a very severe skin disease for which there currently are no approved therapies,” sai
IDEMIA Provides SK Telecom in South Korea with GMSA Compliant Smart Connect Solution to Activate and Manage eSIM Device Lifecycles20.11.2018 12:00 | Tiedote
IDEMIA, the global leader in Augmented Identity, is proud to have been selected by SK Telecom, the number one telecommunication operator in South Korea, to launch the first eSIM Connected watch based on GSMA Consumer standards. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181120005231/en/ Crédits : IDEMIA As a leading actor in the telecom field, IDEMIA is at the forefront of the digital revolution and is committed to bringing protected and convenient experiences to mobile operator customers. Leveraging its industrial leadership and appetite for innovation, IDEMIA will be providing SK Telecom its GSMA compliant solution. Based on IDEMIA’s Smart Connect Subscription management solution also known as remote SIM provisioning, the technology remotely connects the eSIM of the smart watch to the SK Telecom’s network without inserting a physical SIM card. This technology is also compliant with the latest GSMA standards ensuring in
AURAK Hosts ICEWES 201820.11.2018 10:51 | Tiedote
The American University of Ras Al Khaimah (AURAK) hosted their annual three-day conference, The International Conference on Energy, Water, and Environmental Sciences (ICEWES), in cooperation with the Arab German Young Academy of Sciences and Humanities (AGYA) and the International Canadian Association for Sharing Knowledge and Sustainability (IASKS) to bring together researchers and scientists with interests in solving energy, water, and environmental related issues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181119005997/en/ ICEWES 2018 opening ceremony audience at the American University of Ras Al Khaimah (Photo: AETOSWire) The first day of ICEWES commenced with a morning session including the UAE National Anthem, a recitation from the Holy Quran, a welcoming speech from the Vice President of Academic Affairs and Student Success of AURAK, Professor Stephen Wilhite, an AGYA overview from Managing Director, Dr. Sabine Do
Ipsen and 3BP announce First Patient Dosed in Phase I/II study for first-in-class radionuclide (IPN01087)20.11.2018 09:30 | Tiedote
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) and 3BP today announced the first patient has been dosed in a Phase I/II study for the first-in-class radionuclide 177Lu-IPN01087 (formerly known as 3BP-227). IPN01087 is a compound that targets cancer cells in patients with advanced solid tumors which express the Neurotensin Receptor Subtype 1 (NTSR1). The key objective of the Phase I dose-escalation trial (EUDRACT Number 2017-001263-20) is to evaluate the safety and activity, as well as to identify the optimum systemically-administered dose of radiation to treat patients with any of the following solid tumors expressing NTSR1: pancreatic ductal adenocarcinoma, colorectal cancer, gastric cancer, gastrointestinal stromal tumors, Ewing sarcoma and squamous cell carcinoma of the head and neck. Alexandre Lebeaut, Executive Vice President, R&D and Chief Scientific Officer, Ipsen, said: “Ipsen is committed to bringing to cancer patients innovative systemic radiation therapy with targeted ra
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme